NASDAQ · Healthcare · Biotechnology
Caris Life Sciences, Inc.
CAI
Caris Life Sciences, Inc. CEO David Dean Halbert · Market cap $7.8B.
$27.50
+0.40 · +1.48%
52w hi $33.6552w lo $14.19
Off 52w high 9.4%
55
ROUTINE
Current InsiderScore
Corp · 90d
4
0 buys · 4 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $26.00
Section 01
Recent Form 4 filings
9 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Sep 17 | Brian J Brille | Vice Chairman and Executive Vice President | Sell | 400,000 | $30.33 | −$12.13M | 47 |
| Sep 04 | David Baxley Spetzler | President | Sell | 119,212 | $24.76 | −$2.95M | 31 |
| Sep 03 | David Baxley Spetzler | President | Sell | 393,100 | $24.76 | −$9.73M | 55 |
| Sep 03 | David Baxley Spetzler | President | Sell | 84,900 | $25.32 | −$2.15M | 31 |
| May 15 | Jon Halbert | Buy | 68,000 | $14.56 | +$990K | 59 | |
| May 11 | Jeff L Vacirca | Buy | 31,050 | $16.15 | +$501K | 68 | |
| Nov 07 | John Russel Denton | Senior Vice President, General Counsel, and Secretary | Buy | 4,184 | $24.09 | +$101K | 69 |
| Jun 20 | Brian J Brille | Vice Chairman and Executive Vice President | Buy | 30,000 | $21.00 | +$630K | 78 |
| Jun 20 | John Russel Denton | Senior Vice President, General Counsel, and Secretary | Buy | 7,500 | $21.00 | +$158K | 69 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct